menu

Medical Program: Advancing Novel Therapeutics to Address Unmet Mental Health Needs

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Advancing Novel Therapeutics to Address Unmet Mental Health Needs

close
Advancing Novel Therapeutics to Address Unmet Mental Health Needs
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Seelos Therapeutics is leading the charge against central nervous system (CNS) disorders by advancing late-stage therapeutic candidates with proven mechanisms of action for patients with suicidality in post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). And Mario Nacinovich welcomes Dr. Raj Mehra, Chairman, Founder, and CEO of Seelos Therapeutics, to hear all about it.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Seelos Therapeutics is leading the charge against central nervous system (CNS) disorders by advancing late-stage therapeutic candidates with proven mechanisms of action for patients with suicidality in post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). And Mario Nacinovich welcomes Dr. Raj Mehra, Chairman, Founder, and CEO of Seelos Therapeutics, to hear all about it.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 4/9/20